Age, gender, and racial differences in incidence and survival in primary CNS lymphoma

被引:422
作者
Villano, J. L. [1 ]
Koshy, M. [2 ,3 ]
Shaikh, H. [1 ]
Dolecek, T. A. [4 ]
McCarthy, B. J. [4 ]
机构
[1] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL 60680 USA
[2] Univ Illinois, Dept Radiat Therapy, Chicago, IL USA
[3] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[4] Univ Illinois, Dept Epidemiol Biostat, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
Lymphoma; brain tumour; epidemiology; incidence; trends; NERVOUS-SYSTEM LYMPHOMA; HIGH-DOSE METHOTREXATE; NON-HODGKINS-LYMPHOMA; UNITED-STATES; BRAIN-TUMORS; TRENDS; EPIDEMIOLOGY; POPULATION; RADIOTHERAPY;
D O I
10.1038/bjc.2011.357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma that accounts for similar to 4% of newly diagnosed central nervous system (CNS) tumours. The objective of this study was to analyse the epidemiology, incidence, and outcome of these rare tumours. METHODS: Primary brain and CNS lymphoma cases were identified from the Surveillance, Epidemiology, and End Results (SEER) research data sets for the years 1980-2008 for analysis of trends in incidence and survival. SEER*Stat v. 7.0.4 software was used to analyse the data. RESULTS: The overall incidence rate of PCNSL was 0.47 per 100 000 person-years. The incidence was significantly higher in males compared with females, blacks aged 0-49 years at diagnosis compared with whites, and whites aged 50 years and older at diagnosis compared with blacks. After a significant decline in incidence between 1995 and 1999, incidence rates rose slightly; those aged 75 + years at diagnosis had the most dramatic increase in incidence rates over time. Five-year survival rates were significantly higher in whites compared with blacks aged 0-49 years at diagnosis, but was primarily driven by white women aged 0-49 years. CONCLUSION: There is an increase in incidence of PCNSL in the elderly, and elderly blacks have lower incidence compared with white population. Survival remains poor and is negatively dominated by factors associated with HIV infection and advanced age. British Journal of Cancer (2011) 105, 1414-1418. doi:10.1038/bjc.2011.357 www.bjcancer.com Published online 13 September 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:1414 / 1418
页数:5
相关论文
共 33 条
  • [1] Primary central nervous system lymphoma
    Abrey, Lauren E.
    [J]. CURRENT OPINION IN NEUROLOGY, 2009, 22 (06) : 675 - 680
  • [2] [Anonymous], 2013, International Classification of disease for Oncology
  • [3] [Anonymous], SEER STAT DAT INC SE
  • [4] THE STATISTICAL COMPARISON OF RELATIVE SURVIVAL RATES
    BROWN, CC
    [J]. BIOMETRICS, 1983, 39 (04) : 941 - 948
  • [5] The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
    Campo, Elias
    Swerdlow, Steven H.
    Harris, Nancy L.
    Pileri, Stefano
    Stein, Harald
    Jaffe, Elaine S.
    [J]. BLOOD, 2011, 117 (19) : 5019 - 5032
  • [6] CBTRUS, 2011, CBTRUS STAT REP PRIM
  • [7] High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
    Chamberlain, Marc C.
    Johnston, Sandra K.
    [J]. NEURO-ONCOLOGY, 2010, 12 (07) : 736 - 744
  • [8] Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome
    Cote, TR
    Manns, A
    Hardy, CR
    Yellin, FJ
    Hartge, P
    Lemp, G
    West, D
    Singleton, J
    Young, J
    Kerndt, P
    Deapen, D
    Ginzberg, M
    AntonCulver, H
    Lieb, S
    Hopkins, R
    Williams, B
    Liff, J
    Morgan, D
    Parkin, W
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (10) : 675 - 679
  • [9] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA
    FINE, HA
    MAYER, RJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) : 1093 - 1104
  • [10] Cancer statistics for African Americans
    Ghafoor, A
    Jemal, A
    Cokkinides, V
    Cardinez, C
    Murray, T
    Samuels, A
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (06) : 326 - 341